Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Matos

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Early evolutionary divergence between papillary and anaplastic thyroid cancersJ Capdevila, R Mayor, F M Mancuso, et al.
Acta Biomaterialia|June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanomaVanessa Sainz, Liane I F Moura, Carina Peres, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2025
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironmentBárbara Carreira, Rita C Acúrcio, Ana I Matos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Early evolutionary divergence between papillary and anaplastic thyroid cancersJ Capdevila, R Mayor, F M Mancuso, et al.
Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.
Puerto Rico Health Sciences Journal|April 11, 2001
Integrative medicine: a paradigm shift in medical education and practiceM J González, J R Miranda-Massari, E M Mora, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
Silencing the major apple allergen Mal d 1 by using the RNA interference approachLuud J W J Gilissen, Suzanne T H P Bolhaar, Catarina I Matos, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 12, 2025
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against MelanomaLiane If Moura, Alessio Malfanti, Ana I Matos, et al.
Military Medicine|July 13, 2023
Beyond Trauma: High-Volume Critical Care Medicine in a Military Medical Center-Based Military-Civilian PartnershipJeremy P Kilburn, Stephanie M Streit, W Patrick Luan, et al.
Critical Care Medicine|February 8, 2021
Choosing Wisely For Critical Care: The Next FiveJerry J Zimmerman, Lori A Harmon, Pamela L Smithburger, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Early evolutionary divergence between papillary and anaplastic thyroid cancersJ Capdevila, R Mayor, F M Mancuso, et al.
Acta Biomaterialia|June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanomaVanessa Sainz, Liane I F Moura, Carina Peres, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 31, 2025
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironmentBárbara Carreira, Rita C Acúrcio, Ana I Matos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Early evolutionary divergence between papillary and anaplastic thyroid cancersJ Capdevila, R Mayor, F M Mancuso, et al.
Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.
Puerto Rico Health Sciences Journal|April 11, 2001
Integrative medicine: a paradigm shift in medical education and practiceM J González, J R Miranda-Massari, E M Mora, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
Silencing the major apple allergen Mal d 1 by using the RNA interference approachLuud J W J Gilissen, Suzanne T H P Bolhaar, Catarina I Matos, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 12, 2025
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against MelanomaLiane If Moura, Alessio Malfanti, Ana I Matos, et al.
Military Medicine|July 13, 2023
Beyond Trauma: High-Volume Critical Care Medicine in a Military Medical Center-Based Military-Civilian PartnershipJeremy P Kilburn, Stephanie M Streit, W Patrick Luan, et al.
Critical Care Medicine|February 8, 2021
Choosing Wisely For Critical Care: The Next FiveJerry J Zimmerman, Lori A Harmon, Pamela L Smithburger, et al.
Pageof 10